Atlas Trials

Recurrent Primary Peritoneal Carcinosarcoma

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Primary Peritoneal Carcinosarcoma

RecordFirmDate
Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer (NCT06393751)National Cancer Institute (NCI)2025-10-31
MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer (NCT06483048)Mayo Clinic2024-09-20
Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer (NCT05920798)Mayo Clinic2023-09-28

Track Recurrent Primary Peritoneal Carcinosarcoma automatically

Every clearance here is in the API, with alerts when new ones post.